Glaucoma, a neurodegenerative disorder is characterized by damage of ganglion cells of
retina and also its axons. The manner of progression of disease and retinal ganglion cells …

Glaucoma is a multifactorial optic neuropathy in which there is a characteristic acquired loss
of retinal ganglion cells, at levels beyond normal age-related baseline loss, and …

Understanding the molecular mechanism of glaucoma and development of neuroprotectants
is significantly hindered by the lack of a reliable animal model that accurately recapitulates …

In clinical practice, control of IOP remains the mainstay of managing NTG patients, but
consideration must also be given to other factors, especially those that may influence …

Glaucoma is a leading cause of blindness worldwide. In glaucoma, a progressive
dysfunction and death of retinal ganglion cells occurs, eliminating transfer of visual …

Peripheral vision loss followed by “tunnel vision” and eventual irreversible blindness is the
fate of patients afflicted by various forms of glaucoma including primary open-angle …

Glaucoma is a group of optic neuropathies associated with aging and sensitivity to
intraocular pressure (IOP). The disease causes vision loss through the degeneration of …

Intraocular pressure (IOP)-lowering therapy has been shown to arrest or retard the
progression of optic neuropathy typical for glaucoma and can, thus, be described as …

Until recently, the evidence that lowering intraocular pressure (IOP) protects the optic nerve
from glaucomatous damage was weak. Several randomized controlled trials have provided …

Almost all optic neuropathies are untreatable, motivating the search for new therapies that
address the final common pathway of optic nerve disease, retinal ganglion cell loss. These …